EMA Authorised: Artesunate Amivas (artesunate) — Amivas Ireland Ltd

View source ↗

Summary

The European Medicines Agency authorised Artesunate Amivas (artesunate) for malaria, with orphan designation and marketing authorization granted to Amivas Irela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artesunate Amivas (artesunate)

Snippet

Status: Authorised. Therapeutic area: Malaria. MAH: Amivas Ireland Ltd. Decision date: 24/03/2026. Orphan medicine